Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Definium Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $131.56M went out.
  • Fiscal year ended 2025-12-31: from investing, $151.61M went out.
  • Fiscal year ended 2025-12-31: from financing, $267.27M came in.
  • Fiscal year ended 2025-12-31: change in cash, $15.90M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$131.56M-$151.61M-$22.00M$0.00$0.00$289.27M*-$15.90M
2024-12-31-$79.13M$0.00$0.00-$54.00K$984.00K$252.27M*$174.04M
2023-12-31-$64.36M$0.00$7.53M$14.32M*-$42.44M
2022-12-31-$50.14M-$407.00K$42.30M$17.16M*$8.60M
2021-12-31-$45.82M-$297.00K$81.92M$16.90M*$53.45M
2020-12-31-$23.60M$71.99M$24.71M*$73.39M

Each quarter (3 month)

Quarter endRunning the businessFrom investingCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$52.78M*-$316.74M*$860.00K*$761.41M*
2026-03-31-$42.63M$42.00M$1.20M$4.11M*$4.68M
2025-12-31-$42.98M*$34.98M*$0.00*$0.00*$0.00*$245.87M*
2025-09-30-$29.57M*$15.41M*$0.00*$0.00*$0.00*$749.00K*
2025-06-30-$29.60M*-$39.54M*$0.00*$97.00K*$19.55M*
2025-03-31-$29.42M-$162.46M$0.00$237.00K$765.00K*-$190.89M
2024-12-31-$25.35M*$0.00*$0.00*$0.00*$0.00*$3.81M*
2024-09-30-$17.19M*$0.00*$0.00*$0.00*$0.00*$69.35M*
2024-06-30-$19.99M*$0.00*$0.00*$174.00K*$10.61M*
2024-03-31-$16.60M$0.00-$54.00K$465.00K$168.84M*$152.63M
2023-12-31-$20.56M*$0.00*$2.59M*
2023-09-30-$16.63M*$3.09M*$14.31M*
2023-06-30-$13.85M*$1.27M*
2023-03-31-$13.33M$583.00K-$12.73M
2022-12-31-$12.85M*$0.00*$730.00K*
2022-09-30-$9.30M*$0.00*$83.00K*$58.13M*
2022-06-30-$15.13M*$0.00*$0.00*$590.00K*
2022-03-31-$12.87M-$407.00K$123.00K-$13.07M
2021-12-31-$7.83M*$113.00K*$0.00*
2021-09-30-$16.78M*-$27.00K*-$4.00K*$824.00K*
2021-06-30-$11.17M*-$67.00K*-$185.00K*$8.07M*
2021-03-31-$10.04M-$316.00K$82.11M$7.88M*$79.95M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B